The Huntsville City Council laid out more details on the city's proposed tax increment financing (TIF) district in Limestone County,

Post-merger with Eli Lilly's Albali unit on Sept. 11, 2026, AtaiBeckley deregisters all unsold shares from its 2020 and 2021 equity plans.

/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the successful completion of its acquisition of AtaiBeckley Inc. AtaiBeckley is a...

The City of Huntsville has used TIF districts since 2000 to help finance public infrastructure and redevelopment projects.

Global pharmaceutical giants are making a series of massive investments to secure next-generation immunology drugs. AbbVie completed its $10.9 billion…

Pharma giants race to invest in immune therapies as market growth accelerates Big drugmakers double down on next‑gen immunology, from long-lasting antibodies to AI-guided discovery

Eli Lilly draws notice as oral obesity-treatment clinical data advances and defensive healthcare names keep steadier footing amid a broader market retreat and surging Treasury yields.

In the high-stakes world of big pharma, the slower-growing giant now commands the higher price, forcing investors to decide what that premium is truly buying. In the pharmaceutical industry, Merck (MRK) and Eli Lilly (LLY) are direct rivals competing for the same healthcare dollars.